Pfizer COVID vaccine
The Pfizer COVID vaccine was first approved in the United Kingdom late in 2020, for those over 16 years old.
It is a novel mRNA vaccine, having data on merely 30,000 patients. The follow-up monitoring consisted of only two months. On Dec. 9, 2020, Pfizer issued a warning for those having allergies:
|“||Two people who were jabbed with Pfizer’s recently-approved coronavirus vaccine in the UK had to be treated for serious adverse reactions — leading to warnings that those with “significant” allergies may not be able to get it.||”|
|“||An investigation this week identified polyethylene glycol (PEG) as the likely reason two people in the UK suffered anaphylaxis after receiving Pfizer’s COVID vaccine. In September, CHD Chairman RFK, Jr. warned the FDA that PEG in COVID vaccines could lead to severe allergic reactions.||”|
The meeting of the FDA advisory committee is available online, at which several dissented from recommending this vaccine to the public, particularly for those aged 16 to 18 years old.
Testing results show pathogenic priming in older adults.
There is questionable categorizing of severe adverse effects as "non-serious", such as Bell’s Palsy, neuroinflammatory and thrombotic reactions. These can develop into severe conditions and can remain for the rest of one's life.
Issues have been raised as to whether studies have been biased against finding adverse reactions.
Infections increased 300%
According to Karen Kingston, a pharmaceutical marketing expert and biotech analyst with Pfizer, "If you get the Pfizer vax, you’re more likely to get COVID....So, when they weren’t injected, their infection rate was 1.3% and when they got injected, it was 4.34%. It went up by over 300%...They had less infection when they had no protection."
This vaccine requires special, super-cold refrigeration not commonly used at hospitals or medical facilities. It has a shelf life of only 5 days at subfreezing temperatures commonly used by hospitals for vaccines. However, there is no system or accountability to ensure proper refrigeration. When warmed, South Korean doctors have found what appear to be living organisms under a microscope. The FDA has asked a federal judge to wait until the year 2076 and beyond to disclose to the public what is inside the vaccine.
FDA FOIA documents
The documents in question stem from a Freedom of Information Act (FOIA) request filed in August 2021 by Public Health and Medical Professionals for Transparency (PHMPT). In its FOIA request, the group asked the FDA to release “all data and information for the Pfizer vaccine,” including safety and effectiveness data, adverse reaction reports, and a list of active and inactive ingredients. PHMPT, a group comprised of more than 30 medical and public health professionals and scientists from institutions such as Harvard, Yale, and UCLA, initially requested expedited processing of its FOIA submission on the basis there is a “compelling need” for the swift release of the documents in question. PHMPT argued the release of the documents is a matter of urgency at a time where millions of Americans are facing mandates to get vaccinated or face repercussions.
FDA requests 75 years to comply
The U.S. Food and Drug Administration (FDA) asked the court for 75 years to fully release redacted versions of all documents related to the FDA'sa approval of Pfizer’s Comirnaty COVID-19 vaccine. This would mean the entire cache of documents would not be fully released until 2096. The FDA’s initial timeline would have meant the release of the documents would not be completed until 2076, or 55 years from now.
In a filing submitted to a federal judge in November 2021, the Biden Department of Justice (DOJ), arguing on behalf of the FDA, initially claimed the agency could process some 329,000 pages of documents at a rate of only 500 pages per month, in order to have time to redact legally exempt material. According to the DOJ, such material includes “confidential business and trade secret information of Pfizer or BioNTech and personal privacy information of patients who participated in clinical trials.”
FDA knew of risks of death
The first tranche of documents from a Freedom of Information Act (FOIA) request to the Food and Drug Administration (FDA) reveal that, as of February 2021, when Pfizer’s shot was being rolled out worldwide on an emergency basis, the drugmaker had compiled more than 42,000 case reports detailing nearly 160,000 adverse reactions to the jab.
These reactions ranged from mild to severe, and 1,223 were fatal. The majority of these case reports involved people aged between 31 and 50 in the United States.
More than 25,000 nervous system disorders were reported, along with 17,000 musculoskeletal and connective tissue disorders and 14,000 gastrointestinal disorders. A range of different autoimmune conditions were reported, along with some peculiar maladies, including 270 “spontaneous abortions,” and incidences of herpes, epilepsy, heart failure and strokes, among thousands of others.
These side effects were previously known, and have all been logged on the Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System (VAERS) database, which as of December 13, 2021 tracked 3,300 deaths following vaccination with Pfizer’s vaccine, a figure broadly in keeping with the company’s own data.
Critics say that some of these deaths cannot be conclusively linked to vaccination, while others argue that the true number of deaths and adverse effects is underreported.